Asia Pacific Cervical Cancer Diagnostic Testing Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (PAP Testing, HPV Testing, Colposcopy, Cervical Biopsies, Cystoscopy, and Others) and Service Provider (Diagnostics and Research Laboratories, Hospitals and Clinics, Specialty Clinics, and Home Care Services)     

No. of Pages: 133    |    Report Code: TIPRE00027454    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Cervical Cancer Diagnostic Testing Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        APAC Cervical Cancer Diagnostic Testing Market – By Type

1.3.2        APAC Cervical Cancer Diagnostic Testing Market – By Service Provider

1.3.3        APAC Cervical Cancer Diagnostic Testing Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           APAC Cervical Cancer Diagnostic Testing Market – Market Landscape

4.1         Overview

4.2         APAC PEST Analysis

4.3         Experts Opinion

5.           APAC Cervical Cancer Diagnostic Testing Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Escalating Prevalence of Cervical Cancer

5.1.2        Surging HPV Infections

5.2         Market Restraints

5.2.1        Lack of Awareness about the Diagnosis and Treatment Methods

5.3         Market Opportunities

5.3.1        Growing Opportunities in Emerging Countries

5.4         Future Trends

5.4.1        Rising Development and Launch of Innovative Products

5.5         Impact Analysis

6.           Cervical Cancer Diagnostic Testing Market– APAC Analysis

6.1         APAC Cervical Cancer Diagnostic Testing Market Revenue Forecast and Analysis

7.           APAC Cervical Cancer Diagnostic Testing Market Analysis – By Type

7.1         Overview

7.2         APAC Cervical Cancer Diagnostic Testing Market, By Type, 2021 & 2028 (%)

7.3         PAP Testing

7.3.1        Overview

7.3.2        PAP Testing: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

7.4         HPV Testing

7.4.1        Overview

7.4.2        HPV Testing: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

7.5         Colposcopy

7.5.1        Overview

7.5.2        Colposcopy: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

7.6         Cervical Biopsies

7.6.1        Overview

7.6.2        Cervical Biopsies: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

7.7         Cystoscopy

7.7.1        Overview

7.7.2        Cystoscopy: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

7.8         Others

7.8.1        Overview

7.8.2        Others: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

8.           APAC Cervical Cancer Diagnostic Testing Market Analysis – By Service Provider

8.1         Overview

8.2         APAC Cervical Cancer Diagnostic Testing Market Share by Service Provider - 2021 & 2028 (%)

8.3         Diagnostics and Research Laboratories

8.3.1        Overview

8.3.2        Diagnostic Laboratories and Research Laboratories: Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)

8.4         Hospitals and Clinics

8.4.1        Overview

8.4.2        Hospitals and Clinics: Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028  (US$ Million)

8.5         Specialty Clinics

8.5.1        Overview

8.5.2        Specialty Clinics: Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)

8.6         Home Care services

8.6.1        Overview

8.6.2        Home Care Services: Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)

9.           APAC Cervical Cancer Diagnostic Testing Market – Country Analysis

9.1         APAC Cervical Cancer Diagnostic Test Market Revenue and Forecasts To 2028

9.1.1        Overview

9.1.3        APAC: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Country (%)

9.1.3.1          Japan: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

9.1.3.1.1          Overview

9.1.3.1.2          Japan: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

9.1.3.1.3          Japan: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Type (US$ Million)

9.1.3.1.4          Japan: Cervical Cancer Diagnostic Test Market, by Service Provider, 2019–2028 (US$ Million)

9.1.3.2          China: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

9.1.3.2.1          Overview

9.1.3.2.2          China: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

9.1.3.2.3          China: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Type US$ Million)

9.1.3.2.4          China: Cervical Cancer Diagnostic Test Market, by Service Provider, 2019–2028 (US$ Million)

9.1.3.3          India Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

9.1.3.3.1          Overview

9.1.3.3.2          India: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

9.1.3.3.3          India: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Type (US$ Million)

9.1.3.3.4          India: Cervical Cancer Diagnostic Test Market, by Service Provider, 2019–2028 (US$ Million)

9.1.3.4          South Korea: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

9.1.3.4.1          Overview

9.1.3.4.2          South Korea: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

9.1.3.4.3          South Korea: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Type (US$ Million)

9.1.3.4.4          South Korea: Cervical Cancer Diagnostic Test Market, by Service Provider, 2019–2028 (US$ Million)

9.1.3.5          Australia: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

9.1.3.5.1          Overview

9.1.3.5.2          Australia: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

9.1.3.5.3          Australia: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Type (US$ Million)

9.1.3.5.4          Australia: Cervical Cancer Diagnostic Test Market, by Service Provider, 2019–2028 (US$ Million)

9.1.3.6          Rest of APAC: Cervical Cancer Diagnostic Test Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.6.1          Overview

9.1.3.6.2          Rest of APAC: Cervical Cancer Diagnostic Test Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.6.3          Rest of APAC: Cervical Cancer Diagnostic Test Market, by Type, 2019–2028 (US$ Million)

9.1.3.6.4          Rest of APAC: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Service Provider (US$ Million)

10.        Impact Of COVID-19 Pandemic on APAC Cervical Cancer Diagnostic Testing Market

10.1      APAC: Impact Assessment of COVID-19 Pandemic

11.        APAC Cervical Cancer Diagnostic Testing Market–Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      F. Hoffmann-La Roche Ltd.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Abbott

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Quest Diagnostics Incorporated

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      QIAGEN

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Hologic, Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Femasys Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Guided Therapeutics, Inc

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Cooper Companies, Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      BD

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             APAC Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Japan: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Type (US$ Million)

Table 3.             Japan: Cervical Cancer Diagnostic Test Market, by Service Provider – Revenue and Forecast to 2028 (US$ Million)

Table 4.             China: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Type (US$ Million)

Table 5.             China: Cervical Cancer Diagnostic Test Market, by Service Provider – Revenue and Forecast to 2028 (US$ Million)

Table 6.             India: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Type (US$ Million)

Table 7.             India: Cervical Cancer Diagnostic Test Market, by Service Provider – Revenue and Forecast to 2028 (US$ Million)

Table 8.             South Korea: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Type (US$ Million)

Table 9.             South Korea: Cervical Cancer Diagnostic Test Market, by Service Provider – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Australia: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Type (US$ Million)

Table 11.          Australia: Cervical Cancer Diagnostic Test Market, by Service Provider– Revenue and Forecast to 2028  (US$ Million)

Table 12.          Rest of APAC: Cervical Cancer Diagnostic Test Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Rest of APAC: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Service Provider (US$ Million)

Table 14.          Organic Developments

Table 15.          Inorganic Developments

Table 16.          Glossary of Terms

 


LIST OF FIGURES

Figure 1.           APAC Cervical Cancer Diagnostic Testing Market Segmentation

Figure 2.           APAC Cervical Cancer Diagnostic Testing Market, By Country

Figure 3.           APAC Cervical Cancer Diagnostic Testing Market Overview

Figure 4.           PAP Testing Segment Held Largest Share of the Market in 2021

Figure 5.           China is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           APAC: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Impact Analysis of Drivers and Restraints Pertaining to APAC Cervical Cancer Diagnostic Testing Market

Figure 9.           APAC Cervical Cancer Diagnostic Testing Market Forecast to 2028

Figure 10.        APAC Cervical Cancer Diagnostic Testing Market, by Type, 2021 & 2028 (%)

Figure 11.        APAC Pap Testing: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        APAC HPV Testing: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        APAC Colposcopy: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        APAC Cervical Biopsies: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        APAC Cystoscopy: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        APAC Others: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        APAC Cervical Cancer Diagnostic Testing Market Share by Service Provider - 2021 & 2028 (%)

Figure 18.        APAC Diagnostic Laboratories and Research Laboratories: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19.        APAC Hospitals and Clinics: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 20.        APAC Specialty Clinics: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21.        APAC Home Care Services: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 22.        APAC Cervical Cancer Diagnostic Test Market Overview, by Country (2021)

Figure 23.        APAC: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Country (%)

Figure 24.        Japan: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        China: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26.        India: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27.        South Korea: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28.        Australia: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29.        Rest of APAC: Cervical Cancer Diagnostic Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Impact of COVID-19 Pandemic in APAC Country Markets

The List of Companies - Asia Pacific Cervical Cancer Diagnostic Testing Market

  1. Abbott
  2. BD
  3. Cooper Companies, Inc.
  4. F. Hoffmann-La Roche Ltd.
  5. Femasys Inc.
  6. Guided Therapeutics, Inc
  7. Hologic, Inc.
  8. QIAGEN
  9. Quest Diagnostics Incorporated